Rozibafusp alfa is a bispecific fusion protein consisting of an IgG2-κ anti-ICOSL antibody linked to a TNFSF13B (APRIL) domain. It is a research tool for investigating B-cell biology and related autoimmune pathways, with utility in both in vitro binding assays and in vivo preclinical models.